Statin Therapy

Introduction to Statin Mechanism and Effects

Statins are selective, competitive inhibitors of HMG-CoA reductase, primarily affecting lipid metabolism by lowering LDL cholesterol levels by 30-60% depending on the statin and dosage, according to the American College of Cardiology 1
Statin intensity categories are defined by their LDL-C reduction: high-intensity (≥50%), moderate-intensity (30-49%), and low-intensity (<30%), as classified by the American College of Cardiology 2, 3

The American College of Cardiology/American Heart Association guidelines document well-established side effects of statins, including muscle-related side effects (myalgia, myositis, rhabdomyolysis) and a small increased risk of new-onset diabetes, as noted by the American College of Cardiology 4, 3
Monitoring for muscle symptoms is recommended, as it is a known side effect of statins, according to the American College of Cardiology 4
High-intensity statins like atorvastatin 80 mg have a 36% relative increase in new-onset diabetes compared to placebo, while moderate-intensity statins like pravastatin have a lower risk, as reported by the American Diabetes Association 5

Statins have numerous effects beyond cholesterol lowering, but these do not include significant impacts on red blood cell production, as stated by the American College of Cardiology 1

High-intensity statins (≥50% LDL-C reduction) include atorvastatin 40-80 mg and rosuvastatin 20-40 mg, as classified by the American College of Cardiology 2
Moderate-intensity statins (30-49% LDL-C reduction) include atorvastatin 10-20 mg and pravastatin 40-80 mg, as recommended by the American Heart Association 3
Low-intensity statins (<30% LDL-C reduction) include pravastatin 10-20 mg, as stated by the American College of Cardiology 2
Atorvastatin 10 mg reduces LDL-C by approximately 35-39%, while pravastatin 20 mg reduces it by only 23-27%, as reported by the American College of Cardiology 6
Atorvastatin 80 mg (high-intensity) reduces LDL-C by approximately 50-60%, while pravastatin 40 mg (moderate-intensity) reduces it by only 30-34%, according to the American Heart Association 7

The 2018 AHA/ACC guidelines emphasize that statins remain the cornerstone of lipid-lowering therapy, with benefits in reducing cardiovascular events, according to the American College of Cardiology 1
For patients requiring <30% LDL-C reduction, consider pravastatin 10-20 mg, as recommended by the American College of Cardiology 2
For patients requiring 30-49% LDL-C reduction, atorvastatin 10-20 mg is preferred over pravastatin 40-80 mg due to better efficacy at lower doses, as stated by the American Heart Association 3
For patients requiring ≥50% LDL-C reduction, atorvastatin 40-80 mg is required, as recommended by the American College of Cardiology 2
Patients with acute coronary syndrome may benefit from atorvastatin 80 mg, as demonstrated by the PROVE IT trial, with a strength of evidence rated as high 6
Patients with elevated triglycerides may benefit from atorvastatin due to its better triglyceride-lowering effects, as stated by the American College of Cardiology, with a strength of evidence rated as moderate 8

Regular monitoring of liver function is recommended, particularly with higher doses of atorvastatin, as stated by the American Heart Association, with a strength of evidence rated as moderate 8
Atorvastatin 80 mg is associated with higher rates of liver enzyme elevations (3.3%) compared to pravastatin 40 mg (1.1%), as reported by the American College of Cardiology 6
If a patient on statin therapy develops anemia, other causes should be investigated, and complete blood counts are not routinely recommended for statin monitoring in major guidelines, according to the American College of Cardiology 1